Logo
SubscribeSign In
LeaderPortfolio
Billionaire Profile
Maximilian von Baumbach
Global Rank
#671

Image: Public domain | via Wikimedia Commons

Maximilian von Baumbach

CEO, Boehringer Ingelheim
DE
Real-Time Net Worth
$5.76B
As of December 2025
Age
27
Source
Pharma
Industry
healthcare
Citizenship
DE

Biography

Maximilian von Baumbach, a 27-year-old German citizen, is a prominent figure in the pharmaceutical industry with a net worth estimated at $5.7 billion. His wealth stems from his family's significant stake in Boehringer Ingelheim, a global pharmaceutical leader founded in 1885. Baumbach, residing in Ingelheim, Germany, is part of a new generation of wealth inheritors. His career involves managing a portion of the family wealth, and he is part of a family known for its discretion and commitment to innovation.

Wealth Over Time

In-Depth Profile

Early Life

Maximilian von Baumbach, born February 22, 1998, hails from a family deeply rooted in the pharmaceutical industry. As a scion of the von Baumbach family, he is an heir to the Boehringer Ingelheim fortune. This company, founded in 1885, has grown into one of the largest privately held pharmaceutical companies globally.

Rise to Success

Baumbach's wealth is primarily derived from his family's ownership in Boehringer Ingelheim. While specific details of his direct involvement in the company's operations are not widely available, his financial standing places him among the world's wealthiest individuals.

Key Business Strategies

Boehringer Ingelheim, the source of Baumbach's wealth, is known for its focus on innovation, research, and development in human and animal health. The company's key business strategies include developing medicines, vaccines, and advanced therapies. The firm's diverse portfolio, including treatments for COPD, diabetes, and blood clot prevention, has been key to its financial success. The company’s structure has enabled resilience in the face of economic downturns and industry changes.

Philanthropy

While specific details of Maximilian von Baumbach’s personal philanthropic activities are not readily available in the search results, Boehringer Ingelheim, the source of his wealth, is known to support various initiatives. The company is committed to corporate social responsibility through its focus on research, development, and the creation of innovative medicines.